Utility of EFC quality indicators for colposcopy in daily practice: results from an independent, prospective multicenter trial

      Abstract

      Objectives

      The accuracy of colposcopy as the gold standard to manage abnormal screening tests depends on qualification and well defined standards. A recent survey of the European Federation for Colposcopy (EFC) found strong heterogeneity in the practice of colposcopy across Europe. EFC defined four quality indicators (QIs) to enable quality assessment in colposcopy as one tool to harmonize colposcopy standards. We undertook a pilot project to estimate the utility of these QIs for an independent external quality assessment in daily routine colposcopy.

      Study design

      Participating colposcopy clinics used newly developed software for data collection. Data were automatically anonymized, encrypted and stored in a secure relational database located within the clinics’ network and allowed for an independent external benchmarking comparing the performance of participating clinics according to EFC QIs.

      Results

      10,869 patients referred for routine colposcopy were included. On average none of the four EFC QIs was fulfilled. One target was almost met with 83.3% instead of 85% excisional treatments/conizations containing CIN2+ and for another QI the difference of 94.4% instead of 100% cases having a colposcopic examination prior to treatment for abnormal cervical cytology was mainly explained by wrong documentation. For a third QI, visibility of the squamocolumnar junction (SCJ) was only reported in 90.9% instead of 100% but reporting improved to 94.7% after a consensus meeting. The last QI, >80% clear margins in excised lesions/conizations were not considered as useful by some clinics and therefore not documented.

      Discussion and conclusions

      At least 3 out of 4 QIs seemed to be useful for quality assessment in colposcopy but will need rewording and readjustment. All tools for an independent electronic quality assessment with the use of EFC-QI are available and could be used to achieve a high quality standard in colposcopy across Europe.

      Keywords

      To read this article in full you will need to make a payment

      References

        • TOMBOLA Group
        Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial.
        BMJ. 2009; 339: b2548
        • Gage J.C.
        • Hanson V.W.
        • Abbey K.
        • et al.
        Number of cervical biopsies and sensitivity of colposcopy.
        Obstet Gynecol. 2006; 108: 264-272
        • Massad L.S.
        • Jeronimo J.
        • Katki H.A.
        • Schiffman M.
        The accuracy of colposcopic grading for detection of high-grade cervical intraepithelial neoplasia.
        J Low Genit Tract Dis. 2009; 13: 137-144
        • European Federation for Colposcopy
        1st EFC satellite meeting 2011, Berlin, Germany.
        2011 (http://www.e-f-c.org/media/EFc_NewsletterFeb201211.pdf)
        • Arbyn M.
        • Anttila A.
        • Jordan J.
        • et al.
        European guidelines for quality assurance in cervical cancer screening. Second edition – summary document.
        Ann Oncol. 2010; 21: 448-458
        • Moss E.L.
        • Arbyn M.
        • Dollery E.
        • et al.
        European Federation of Colposcopy quality standards Delphi consultation.
        Eur J Obstet Gynecol Reprod Biol. 2013; 170: 255-258
        • Luyten A.
        • Buttmann-Schweiger N.
        • Hagemann I.
        • et al.
        Utility and reproducibility of the International Federation for Cervical Pathology and Colposcopy classification of transformation zones in daily practice: a multicenter study of the German Colposcopy Network.
        J Low Genit Tract Dis. 2014; ([Epub ahead of print])
        • Bornstein J.
        • Bentley J.
        • Bosze P.
        • et al.
        2011 colposcopic terminology of the International Federation for Cervical Pathology and Colposcopy.
        Obstet Gynecol. 2012; 120: 166-172
        • Luyten A.
        • Buttmann-Schweiger N.
        • Luyten K.
        • et al.
        Early detection of CIN3 and cervical cancer during long-term follow-up using HPV/Pap smear co-testing and risk-adapted follow-up in a locally organised screening programme.
        Int J Cancer. 2014; 135: 1408-1416
        • Kyrgiou M.
        • Valasoulis G.
        • Stasinou S.M.
        • et al.
        Proportion of cervical excision for cervical intraepithelial neoplasia as a predictor of pregnancy outcomes.
        Int J Gynaecol Obstet. 2014; 128: 141-147
        • Kyrgiou M.
        • Mitra A.
        • Arbyn M.
        • et al.
        Fertility and early pregnancy outcomes after treatment for cervical intraepithelial neoplasia: systematic review and meta-analysis.
        BMJ. 2014; 349: g6192
        • Castanon A.
        • Landy R.
        • Brocklehurst P.
        • et al.
        Risk of preterm delivery with increasing depth of excision for cervical intraepithelial neoplasia in England: nested case–control study.
        BMJ. 2014; 349: g6223